SCHEMBL14420191

SCHEMBL14420191

CC(C)(O)c1ccc2c(c1)/C(=C/CCN1CCC(N)(Nc3ccc(Cl)cc3)CC1)c1cccnc1CO2

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 2/20 0.72
▸ CHRM2 P08172 1/20 0.49
▸ CCR5 P51681 1/20 0.49
▸ HRH1 P35367 6/20 0.33
▸ ADRA1A P35348 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ HTR2B P41595 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14579806 0.93 CCR1 (0.74) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL652668 0.92 CCR1 (0.67) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL652669 0.92 CCR1 (0.67) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL654596 0.91 CCR1 (0.68) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL654595 0.91 CCR1 (0.68) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL654046 0.90 CCR1 (0.67) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL654045 0.90 CCR1 (0.67) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL10288240 0.88 CCR1 (0.81) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL10288262 0.88 CCR1 (0.81) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL656029 0.87 CCR1 (0.78) CCR1CHRM2CCR5HRH1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271176-B2 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-09-18 — — US disclosed
Send feedback